405 related articles for article (PubMed ID: 15589520)
1. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.
Nonaka N; Shioda S; Banks WA
Exp Neurol; 2005 Jan; 191(1):137-44. PubMed ID: 15589520
[TBL] [Abstract][Full Text] [Related]
2. Effects of lipopolysaccharide on leptin transport across the blood-brain barrier.
Nonaka N; Hileman SM; Shioda S; Vo TQ; Banks WA
Brain Res; 2004 Jul; 1016(1):58-65. PubMed ID: 15234252
[TBL] [Abstract][Full Text] [Related]
3. Effect of spinal cord injury on the permeability of the blood-brain and blood-spinal cord barriers to the neurotropin PACAP.
Banks WA; Kastin AJ; Arimura A
Exp Neurol; 1998 May; 151(1):116-23. PubMed ID: 9582259
[TBL] [Abstract][Full Text] [Related]
4. Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.
Banks WA; Kastin AJ; Komaki G; Arimura A
J Pharmacol Exp Ther; 1993 Nov; 267(2):690-6. PubMed ID: 8246142
[TBL] [Abstract][Full Text] [Related]
5. Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse.
Banks WA; Goulet M; Rusche JR; Niehoff ML; Boismenu R
J Pharmacol Exp Ther; 2002 Sep; 302(3):1062-9. PubMed ID: 12183664
[TBL] [Abstract][Full Text] [Related]
6. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase activating polypeptide (PACAP) can cross the vascular component of the blood-testis barrier in the mouse.
Banks WA; Kastin AJ; Komaki G; Arimura A
J Androl; 1993; 14(3):170-3. PubMed ID: 8407571
[TBL] [Abstract][Full Text] [Related]
8. Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide.
Banks WA; Kastin AJ; Brennan JM; Vallance KL
Exp Neurol; 1999 Mar; 156(1):165-71. PubMed ID: 10192787
[TBL] [Abstract][Full Text] [Related]
9. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
[TBL] [Abstract][Full Text] [Related]
10. Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models.
Dogrukol-Ak D; Kumar VB; Ryerse JS; Farr SA; Verma S; Nonaka N; Nakamachi T; Ohtaki H; Niehoff ML; Edwards JC; Shioda S; Morley JE; Banks WA
J Cereb Blood Flow Metab; 2009 Feb; 29(2):411-22. PubMed ID: 19002200
[TBL] [Abstract][Full Text] [Related]
11. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection.
Matsuda K; Maruyama K; Miura T; Uchiyama M; Shioda S
Neurosci Lett; 2005 Sep; 386(1):9-13. PubMed ID: 15975713
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons.
Shintani N; Suetake S; Hashimoto H; Koga K; Kasai A; Kawaguchi C; Morita Y; Hirose M; Sakai Y; Tomimoto S; Matsuda T; Baba A
Regul Pept; 2005 Mar; 126(1-2):123-8. PubMed ID: 15620425
[TBL] [Abstract][Full Text] [Related]
13. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.
Farkas O; Tamás A; Zsombok A; Reglodi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
Regul Pept; 2004 Dec; 123(1-3):69-75. PubMed ID: 15518895
[TBL] [Abstract][Full Text] [Related]
14. The TAT peptide endows PACAP with an enhanced ability to traverse bio-barriers.
Yu R; Zeng Z; Guo X; Zhang H; Liu X; Ding Y; Chen J
Neurosci Lett; 2012 Oct; 527(1):1-5. PubMed ID: 22939769
[TBL] [Abstract][Full Text] [Related]
15. Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons.
Banks WA; Uchida D; Arimura A; Somogyvári-Vigh A; Shioda S
Ann N Y Acad Sci; 1996 Dec; 805():270-7; discussion 277-9. PubMed ID: 8993409
[TBL] [Abstract][Full Text] [Related]
16. Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine.
Amin FM; Schytz HW
J Headache Pain; 2018 May; 19(1):35. PubMed ID: 29785578
[TBL] [Abstract][Full Text] [Related]
17. Changes in pituitary adenylate cyclase activating polypeptide expression in urinary bladder pathways after spinal cord injury.
Zvarova K; Dunleavy JD; Vizzard MA
Exp Neurol; 2005 Mar; 192(1):46-59. PubMed ID: 15698618
[TBL] [Abstract][Full Text] [Related]
18. Effect of middle cerebral artery occlusion on the passage of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier in the rat.
Somogyvári-Vigh A; Pan W; Reglödi D; Kastin AJ; Arimura A
Regul Pept; 2000 Jul; 91(1-3):89-95. PubMed ID: 10967205
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactivity in the brain of a teleost, Uranoscopus japonicus: immunohistochemical relationship between PACAP and adenohypophysial hormones.
Matsuda K; Nagano Y; Uchiyama M; Onoue S; Takahashi A; Kawauchi H; Shioda S
Regul Pept; 2005 Mar; 126(1-2):129-36. PubMed ID: 15620426
[TBL] [Abstract][Full Text] [Related]
20. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
